NBIX - NEUROCRINE BIOSCIENCES INC
128.13
-1.510 -1.178%
Share volume: 903,600
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$129.64
-1.51
-0.01%
Summary score
27%
Profitability
0%
Dept financing
38%
Liquidity
75%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.39%
Return on assets
-11.66%
Return on sales
-456.93%
Return on invested capital
-154.35%
Total debt ratio
29.9%
Debt ratio change over timeo
0%
Current Ratio
13.51%
Quick Ratio
16.87%
Cash Position Ratio
5.48%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.61%
Return on assets
-12.17%
Return on sales
-456.93%
Return on invested capital
-129.8%
Total debt ratio
34.39%
Debt ratio change over timeo
0%
Current Ratio
13.53%
Quick Ratio
16.87%
Cash Position Ratio
5.91%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-3.2%
Return on assets
-0.78%
Return on sales
-9.86%
Return on invested capital
-5.99%
Total debt ratio
55.01%
Debt ratio change over time
0%
Current Ratio
14.38%
Quick Ratio
14.37%
Cash Position Ratio
7.02%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NBIX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -15.39% | 6.52% | 16.07% | 8% |
| Return on assets | -11.66% | 3.2% | 7.46% | 5.12% |
| Return on sales | -456.93% | 44.03% | 59.59% | 42.46% |
| Return on invested capital | -154.35% | 9.05% | 13.06% | 8.23% |
| Profitability | 0% | 57% | 100% | 63% |
| Total debt ratio | 29.9% | 60.67% | 65.75% | 46.57% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 36% | 23% | 25% | 18% |
| Current Ratio | 13.53% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 16.87% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 5.91% | 0.33% | 1.09% | 0.45% |
| Liquididy | 75% | 17% | 13% | 10% |
| Short-term ratios | NBIX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -16.61% | 6.57% | 13.54% | 7.21% |
| Return on assets | -12.17% | 3.23% | 6.63% | 5.05% |
| Return on sales | -456.93% | 44.59% | 57.77% | 41.29% |
| Return on invested capital | -129.8% | 9.41% | 12.01% | 7.62% |
| Profitability | 0% | 63% | 100% | 66% |
| Total debt ratio | 34.39% | 60.55% | 63.84% | 45.95% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 38% | 24% | 25% | 18% |
| Current Ratio | 13.53% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 16.87% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 5.91% | 0.33% | 1.09% | 0.45% |
| Liquididy | 75% | 18% | 14% | 9% |